SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (0.341%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Jupiter identifies further cost saving

22 May 2025 10:03

RNS Number : 7871J
Jupiter Fund Management PLC
22 May 2025
 

Jupiter identifies further cost saving opportunities

 

Jupiter Fund Management plc (Jupiter or the Group)

 

Jupiter today announces an update to management expectations for operating costs, as a result of ongoing management actions.

 

Through our resolute focus on cost discipline, and consistent with our strategic objective of reducing undue complexity, we have identified further opportunities to deliver cost efficiencies.

 

The initial target is £15m annualised savings, which will be fully implemented on a run rate basis no later than the end of 2026. These annualised savings are in addition to the cost savings already achieved within the management expectations previously provided for 2025, and are one of a number of actions we are taking towards achieving our medium-term target of a 70% cost:income ratio.

 

Management expectations for non-compensation costs for 2025 have accordingly now improved from £110m to £105m. All other management expectations for 2025 remain unchanged from those published with our full year 2024 results on 28 February.

 

More details will be provided at the H1 2025 interim results on 25 July, along with further information on progress made towards our initial target.

 

Estimated group assets under management at 20 May 2025 were over £45bn. Net flows since the end of the first quarter have been broadly flat, with rebuilding of momentum in the institutional channel.

 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the UK Market Abuse Regulations ("MAR"). The person responsible for making this announcement is Helen Archbold, Company Secretary.

 

For further information please contact:

 

Investors

Media

Jupiter

Sam Fuschillo

+44 (0)20 3817 1530

Victoria Howley

+44 (0)20 3817 1657

Edelman Smithfield

Hastings Tarrant

+44 (0)7813 407 665

Andrew Wilde

+44 (0)7786 022 022

 

LEI Number: 5493003DJ1G01IMQ7S28

 

 

Forward-looking statements

This announcement contains forward-looking statements with respect to the financial condition, results of operations and businesses of the Group. Such statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by forward-looking statements and forecasts. Forward-looking statements and forecasts are based on the Directors' current view and information known to them at the date of this announcement. The Directors do not make any undertaking to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDVLLBLEELEBBV
Date   Source Headline
10th Jun 20263:15 pmRNSTransaction in Own Shares - Replacement
9th Jun 202612:15 pmRNSHolding(s) in Company
8th Jun 20264:00 pmRNSTransaction in Own Shares
2nd Jun 20265:19 pmRNSHolding(s) in Company
1st Jun 202611:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSTotal Voting Rights
28th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20263:45 pmRNSTransaction in Own Shares
18th May 20263:30 pmRNSTransaction in Own Shares
11th May 20264:57 pmRNSTransaction in Own Shares
8th May 20264:00 pmRNSHolding(s) in Company
7th May 20263:30 pmRNSHolding(s) in Company
7th May 20261:00 pmRNSResult of AGM
5th May 20264:00 pmRNSTransaction in Own Shares
5th May 20263:00 pmRNSHolding(s) in Company
5th May 20262:45 pmRNSHolding(s) in Company
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20262:45 pmRNSHolding(s) in Company
28th Apr 202612:45 pmRNSHolding(s) in Company
27th Apr 20264:02 pmRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTrading Update and Notice of Results
20th Apr 202612:20 pmRNSTransaction in Own Shares
14th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:00 pmRNSTransaction in Own Shares
8th Apr 20267:00 amRNSShare Buyback Programme
1st Apr 20263:00 pmRNSDirector/PDMR Shareholding
30th Mar 20263:00 pmRNSDirector/PDMR Shareholding
27th Mar 20263:30 pmRNSDirector/PDMR Shareholding
26th Mar 202612:12 pmRNSHolding(s) in Company
25th Mar 20264:51 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
24th Mar 20262:00 pmRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20262:00 pmRNSHolding(s) in Company
4th Mar 202612:30 pmRNSHolding(s) in Company
4th Mar 202612:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
27th Feb 20263:30 pmRNSDirector Shareholding
27th Feb 20263:15 pmRNSTotal Voting Rights
26th Feb 20265:00 pmRNSCancellation of Treasury Shares
26th Feb 20267:00 amRNSAnnual Financial Report
9th Feb 20263:45 pmRNSHolding(s) in Company
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
5th Feb 20262:42 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
2nd Feb 20261:30 pmRNSHolding(s) in Company
2nd Feb 20269:53 amRNSCompletion of Acquisition of CCLA
22nd Jan 20262:04 pmRNSHolding(s) in Company
7th Jan 20263:15 pmRNSHolding(s) in Company
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.